Does hepatic oxidative stress enhance activation of nuclear factor-E2-related factor in patients with nonalcoholic steatohepatitis?

Antioxidants and Redox Signaling

Volumn 20, Issue 3, 2014, Pages 538-543

  Takahashi, Yurimi ^a   Kobayashi, Yoshimasa ^a   Kawata, Kazuhito ^a   Kawamura, Kinya ^a   Sumiyoshi, Shinichi ^a   Noritake, Hidenao ^a   Watanabe, Shinya ^a   Chida, Takeshi ^a   Souda, Kenichi ^a   Sakaguchi, Takanori ^a   Nakamura, Hirotoshi ^a   Suda, Takafumi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE 2; HEME OXYGENASE 1; NUCLEAR FACTOR; NUCLEAR FACTOR E2 RELATED FACTOR; THIOREDOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; BIOACCUMULATION; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER CELL; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE SECTION; TRANSCRIPTION INITIATION; UPREGULATION;

ADULT; AGED; ANTIOXIDANTS; BIOPSY; DEOXYGUANOSINE; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LIVER; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84892601947     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5470     Document Type: Review

References (9)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, and Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023, 2012.
2. Gong P and Cederbaum AI. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 43: 144-153, 2006. (Pubitemid 43733601)
3. Kawata K, Kobayashi Y, Souda K, Kawamura K, Sumiyoshi S, Takahashi Y, Noritake H, Watanabe S, Suehiro T, and Nakamura H. Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. Antioxid Redox Signal 13: 259-268, 2010.
4. Klaassen CD and Reisman SA. Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol Appl Pharmacol 244: 57-65, 2010.
5. Kwak MK, Itoh K, Yamamoto M, and Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 22: 2883-2892, 2002. (Pubitemid 34437448)
6. Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52: 774-788, 2010.
7. Nguyen T, Sherratt PJ, Huang HC, Yang CS, and Pickett CB. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278: 4536-4541, 2003. (Pubitemid 36800950)
8. Nguyen T, Yang CS, and Pickett CB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37: 433-441, 2004. (Pubitemid 38901076)
9. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37: 56-62, 2002. (Pubitemid 34713055)